Add Formweb to your mobile device
Search results for:
ustekinumab
ustekinumab
| Drug Name | Form | Strength | Notes |
|---|---|---|---|
| Imuldosa | SOLUTION, INTRAVENOUS | srlf 5 mg/mL | |
| Otulfi | SOLUTION, INTRAVENOUS | aauz 5 mg/mL | |
| Pyzchiva | SOLUTION, INTRAVENOUS | ttwe 5 mg/mL | |
| Selarsdi | SOLUTION, INTRAVENOUS | aekn 5 mg/mL | |
| Starjemza | SOLUTION, INTRAVENOUS | hmny 5 mg/mL | |
| Steqeyma | SOLUTION, INTRAVENOUS | stba 5 mg/mL | |
| Wezlana | SOLUTION, INTRAVENOUS | auub 5 mg/mL | |
| Yesintek | SOLUTION, INTRAVENOUS | kfce 5 mg/mL | |
| Stelara | SOLUTION, INTRAVENOUS | 5 mg/mL | |
| Imuldosa Prefilled Syringe | SOLUTION, SUBCUTANEOUS | srlf 45 mg/0.5 mL | |
| Pyzchiva | SOLUTION, SUBCUTANEOUS | ttwe 45 mg/0.5 mL | |
| Selarsdi | SOLUTION, SUBCUTANEOUS | aekn 45 mg/0.5 mL | |
| Steqeyma | SOLUTION, SUBCUTANEOUS | stba 45 mg/0.5 mL | |
| Wezlana | SOLUTION, SUBCUTANEOUS | auub 45 mg/0.5 mL | |
| Yesintek | SOLUTION, SUBCUTANEOUS | kfce 45 mg/0.5 mL | |
| Stelara | SOLUTION, SUBCUTANEOUS | 45 mg/0.5 mL |
Last updated: May. 12, 2026
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Restricted Restricted Medication
This medication is Inpatient Non-formulary and Restricted to Outpatient Use. Inpatient use requires approval by a physician department leader (i.e. Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.
See HERE for more information and workflow.
See HERE for additional pharmacy workflow details.